Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON37719Withdrawn
Open-label trial of citalopram in obsessive compulsive disorder (OCD) (3 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Serotonin system function by phMRI with citalopram challenge, Microarchitecture of serotonin projections by DTI and 1 more. Planned start Jan 2012; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON37719.